SPPH

Healthcare Biotechnology

Spencer Pharmaceutical Inc.

$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

1.34M

Avg Volume

3,264

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.03

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(142.1%)

Liquidity & Leverage

Current Ratio

0.28

Quick Ratio

0.28

Total Cash

455,928

Total Debt

1.17M

About

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.